BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 141 filers reported holding BIOSCRIP INC in Q2 2014. The put-call ratio across all filers is 4.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $390,000 | +20.4% | 182,107 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $324,000 | -8.5% | 182,107 | -3.8% | 0.00% | 0.0% |
| Q3 2015 | $354,000 | -33.3% | 189,377 | +29.6% | 0.00% | 0.0% |
| Q2 2015 | $531,000 | -20.9% | 146,146 | -3.5% | 0.00% | 0.0% |
| Q1 2015 | $671,000 | -41.8% | 151,452 | -8.1% | 0.00% | -50.0% |
| Q4 2014 | $1,152,000 | +1.1% | 164,767 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $1,139,000 | -9.2% | 164,767 | -1.6% | 0.00% | 0.0% |
| Q2 2014 | $1,255,000 | +7.4% | 167,367 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,168,000 | -14.4% | 167,367 | +4.4% | 0.00% | -33.3% |
| Q4 2013 | $1,364,000 | -46.9% | 160,367 | -45.2% | 0.00% | -40.0% |
| Q3 2013 | $2,567,000 | -68.4% | 292,429 | -40.7% | 0.01% | -66.7% |
| Q2 2013 | $8,129,000 | – | 492,733 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
| DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
| Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
| NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
| KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
| First Washington CORP | 454,200 | $3,788,000 | 2.12% |
| GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
| ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
| True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |